Cryo-Cell International, Inc. (CCEL) Stock Overview
Explore Cryo-Cell International, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Cryo-Cell International, Inc. (CCEL)
Key Financials
Key Financials
Market Cap
28.2M
P/E Ratio
-11.86
EPS (TTM)
$-0.33
ROE
0.14%
CCEL Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of Cryo-Cell International, Inc. (AMEX: CCEL) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cryo-Cell International, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CCEL on the AMEX shows an RSI of 50.83, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.88 for the AMEX listing.
Key metrics behind Cryo-Cell International, Inc.'s AMEX-traded stock include a P/E ratio of -11.86 and a market capitalization of 28.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CCEL on the AMEX.